zurniimtpeМедицина труда и промышленная экологияRussian Journal of Occupational Health and Industrial Ecology1026-94282618-8945FSBSI “Izmerov Research Institute of Occupational Health”10.31089/1026-9428-2018-10-33-38zurniimtpe-1285Research ArticleОБЗОР ЛИТЕРАТУРЫLITERATURE REVIEWИзолированная офисная гипертония (гипертония «белого халата») в клинике Медицины труда (аналитический обзор)Isolated office hypertension («White coat» hypertension) in occupational medicine (analytic review)https://orcid.org/0000-0003-0539-569XНосовА. Е.NosovAlexandr E.

Носов Александр Евгеньевич, зав. стационаром (отд. профпатологии терапевтического профиля) ФБУН «ФНЦ МПТ УРЗН», канд. мед. наук.

ул. Монастырская, 82, Пермь, 614045

82, Monastyrskaya Str., Perm, 614045

nosov@fcrisk.ruhttps://orcid.org/0000-0003-3344-3361ВласоваЕ. М.VlasovaElena M.

Власова Елена Михайловна, зав. профцентром ФБУН «ФНЦ МПТ УРЗН», канд. мед. наук

ул. Монастырская, 82, Пермь, 614045

82, Monastyrskaya Str., Perm, 614045

vlasovaem@fcrisk.ruБайдинаА. С.BaydinaAnastasiya S.

Байдина Анастасия Сергеевна, врач-кардиолог ФБУН «ФНЦ МПТ УРЗН», канд. мед. наук

ул. Монастырская, 82, Пермь, 614045

82, Monastyrskaya Str., Perm, 614045

https://orcid.org/0000-0001-5850-7232АлексеевВ. Б.AlekseevVadim B.

Алексеев Вадим Борисович, дир. ФБУН «ФНЦ МПТ УРЗН», д-р мед. наук

ул. Монастырская, 82, Пермь, 614045

82, Monastyrskaya Str., Perm, 614045

vadim@fcrisk.ruФБУН «Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения»РоссияFederal Scientific Center for Medical and Preventive Health Risk Management TechnologiesRussian Federation2018180220190103338Copyright © Носов А.Е., Власова Е.М., Байдина А.С., Алексеев В.Б., 20192019Носов А.Е., Власова Е.М., Байдина А.С., Алексеев В.Б.Nosov A.E., Vlasova E.M., Baydina A.S., Alekseev V.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.journal-irioh.ru/jour/article/view/1285

Артериальная гипертония представляет значимую проблему при экспертизе профпригодности у работников, занятых на тяжелых работах и на работах с вредными и (или) опасными условиями труда. При принятии экспертных решений необходимо учитывать медицинские противопоказания, интерпретация которых может представлять определенные трудности в практической работе. Систематизированы литературные данные по диагностике и клинической значимости изолированной офисной артериальной гипертонии (АГ; гипертонии «белого халата»).

Arterial hypertension is a significant problem for occupational fitness examination in workers engaged into heavy work and exposed to hazardous and (or) jeopardy work conditions. In expert decisions, necessity is to consider medical contraindications which are difficult to interpret in practice. The authors systematized literature data on diagnosis and clinical importance of isolated office hypertension («white coat» hypertension).

изолированная офисная артериальная гипертонияэкспертиза профпригодноститрудовой прогнозisolated office arterial hypertensionoccupational fitness examinationwork prognosisReferencesРекомендации по лечению артериальной гипертонии. ESH/ESC 2013. Рабочая группа по лечению артериальной гипертонии Европейского Общества Гипертонии и Европейского Общества Кардиологов. Росс. кардиологический ж-л. 2014; 105 (1): 7–94.Recommendations for the treatment of arterial hypertension. ESH/ESC 2013. Working Group on the Treatment of Hypertension of the European Society of Hypertension and the European Society of Cardiology. Rossiyskiy kardiologicheskiy zhurnal. 2014; 105 (1): 7–94 (in Russian).Mancia G., Bertinieri G., Grassi G., Parati G., Pomidossi G., Ferrari A., et al. Effects of blood pressure measurement by the doctor on patients blood pressure and heart rate. Lancet. 1983; 2: 695–8 DOI:10.1016/S0140–6736(83)92244–4Mancia G., Bertinieri G., Grassi G., Parati G., Pomidossi G., Ferrari A., et al. Eff ects of blood pressure measurement by the doctor on patients blood pressure and heart rate. Lancet. 1983; 2: 695–8 DOI:10.1016/S0140–6736(83)92244–4Mancia G., Bombelli M., Seravalle M., Grassi G. Diagnosis and management of patients with white- coat and masked hypertension. Nat. Rev. Cardiol. 2011; 8: 686–93 DOI:10.1038/nrcardio.2011.115Mancia G., Bombelli M., Seravalle M., Grassi G. Diagnosis and management of patients with white- coat and masked hypertension. Nat. Rev. Cardiol. 2011; 8: 686–93 DOI:10.1038/nrcardio.2011.115Pickering T.G., James G.D., Boddie C., Harshfield G.A., Blank S., Laragh J.H. How common is white coat hypertension? JAMA. 1988; 259: 225–28 DOI:10.1001/jama.259.2.225Pickering T.G., James G.D., Boddie C., Harshfield G.A., Blank S., Laragh J.H. How common is white coat hypertension? JAMA. 1988; 259: 225–28 DOI:10.1001/jama.259.2.225Franklin S.S., Thijs L., Hansen T.W. O’Brien Е., Staessen J.A. White-Coat Hypertension. New Insights From Recent Studies. Hypertension. 2013; 62: 982–7 DOI:10.1161/hypertensionaha.113.01275Franklin S.S., Thijs L., Hansen T.W. O’Brien Е., Staessen J.A. White-Coat Hypertension. New Insights From Recent Studies. Hypertension. 2013; 62: 982–7 DOI:10.1161/hypertensionaha.113.01275O’Brien E., Parati G., Stergiou G., Asmar R., Beilin L., Bilo G. et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J. Hypertens. 2013; 31(9): 1731–68 DOI:10.1097/HJH.0b013e328363e964O’Brien E., Parati G., Stergiou G., Asmar R., Beilin L., Bilo G. et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J. Hypertens. 2013; 31(9): 1731–68 DOI:10.1097/HJH.0b013e328363e964.Fagard Rh., Cornelissen V.A. Incidence of cardiovascular events in white-coat, masked and sustained hypertension vs. true normotension: a meta-analysis. J. Hypertens. 2007; 25: 2193–8 DOI:10.1097/hjh.0b013e3282ef6185Fagard Rh., Cornelissen V.A. Incidence of cardiovascular events in white-coat, masked and sustained hypertension vs. true normotension: a meta-analysis. J. Hypertens. 2007; 25: 2193–8 DOI:10.1097/hjh.0b013e3282ef6185Thijs L., Staessen J., O’Brien E., Amery A., Atkins N., Baumgart P. et al. The ambulatory blood pressurein normotensiveand hypertensive subjects: resultsfrom an international database. Neth J Med. 1995; 46(2): 106–14 DOI:10.1016/0300–2977(94)00057-gThijs L., Staessen J., O’Brien E., Amery A., Atkins N., Baumgart P. et al. The ambulatory blood pressurein normotensiveand hypertensive subjects: resultsfrom an international database. Neth J Med. 1995; 46(2): 106–14 DOI:10.1016/0300–2977(94)00057-gLovibond K., JowettS., Barton P., Caulfi eld M., Heneghan C., Hobbs F.D. et al. Cost-eff ectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011; 378: 1219–30 DOI:10.1016/s0140–6736(11)61184–7Lovibond K., JowettS., Barton P., Caulfi eld M., Heneghan C., Hobbs F.D. et al. Cost-eff ectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011; 378: 1219–30 DOI:10.1016/s0140–6736(11)61184–7Watson R.D., Lumb R., Young M.A., Stallard T.J., Davies P., Littler W.A. Variation in cuffblood pressure in untreated outpatients with mild hypertension — implications for initiating antihypertensive treatment. J. Hypertens. 1987; 5: 207–21 DOI:10.1097/00004872–198704000–00012Watson R.D., Lumb R., Young M.A., Stallard T.J., Davies P., Littler W.A. Variation in cuffblood pressure in untreated outpatients with mild hypertension — implications for initiating antihypertensive treatment. J. Hypertens. 1987; 5: 207–21 DOI:10.1097/00004872–198704000–00012Colloca L., Finniss D. Nocebo effects, patient-clinician communication, and therapeuticoutcomes. JAMA. 2012; 307: 567–8 DOI:10.1001/jama.2012.115Colloca L., Finniss D. Nocebo effects, patient-clinician communication, and therapeuticoutcomes. JAMA. 2012; 307: 567–8 DOI:10.1001/jama.2012.115Mancia G. Clinical significance of white-coat hypertension. J. Hypertens. 2016; 34: 623–6 DOI:10.1097/hjh.0000000000000879Mancia G. Clinical significance of white-coat hypertension. J. Hypertens. 2016; 34: 623–6 DOI:10.1097/hjh.0000000000000879Verdecchia P., Schillaci G., Borgioni C., Ciucci A., Gattobigio R., Sacchi N. et al. Identifi cation of subjects with white-coat hypertension and persistently normal ambulatory blood pressure. Blood Press Monit. 1996; 1: 217–22.Verdecchia P., Schillaci G., Borgioni C., Ciucci A., Gattobigio R., Sacchi N. et al. Identifi cation of subjects with white-coat hypertension and persistently normal ambulatory blood pressure. Blood Press Monit. 1996; 1: 217–22.Kikuya M., Hansen T.W., Thijs L., Björklund-Bodegård K., Kuznetsova T., Ohkubo T. et al. International Database on Ambulatoryblood pressure monitoring in relation to Cardiovascular Outcomes Investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007; 115: 2145–52 DOI:10.1161/circulationaha.106.662254Kikuya M., Hansen T.W., Thijs L., Björklund-Bodegård K., Kuznetsova T., Ohkubo T. et al. International Database on Ambulatoryblood pressure monitoring in relation to Cardiovascular Outcomes Investigators. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007; 115: 2145–52 DOI:10.1161/circulationaha.106.662254de la Sierra A., Banegas J.R., Oliveras A., Gorostidi M., Segura J., de la Cruz J.J. et al. Clinical differences between resistant hypertensives and patients treated and controlled with three of less drugs. J. Hypertens. 2012; 30: 1211–1216 DOI:10.1097/HJH.0b013e328353634ede la Sierra A., Banegas J.R., Oliveras A., Gorostidi M., Segura J., de la Cruz J.J. et al. Clinical differences between resistant hypertensives and patients treated and controlled with three of less drugs. J. Hypertens. 2012; 30: 1211–1216 DOI:10.1097/HJH.0b013e328353634ede la Sierra A., Segura J., Banegas J.R., Gorostidi M., de la Cruz J.J., Armario P. et al. Clinical features of 8295 patients with resistant hypertension classifi ed on the basis of ambulatory blood pressure monitoring. Hypertension. 2011; 57: 898–902 DOI:10.1161/hypertensionaha.110.168948de la Sierra A., Segura J., Banegas J.R., Gorostidi M., de la Cruz J.J., Armario P. et al. Clinical features of 8295 patients with resistant hypertension classifi ed on the basis of ambulatory blood pressure monitoring. Hypertension. 2011; 57: 898–902 DOI:10.1161/hypertensionaha.110.168948Grassi G., Esler M. How to assess sympathetic activity in humans. J. Hypertens. 1999; 17: 719–34 DOI:10.1097/00004872–199917060–00001Grassi G., Esler M. How to assess sympathetic activity in humans. J. Hypertens. 1999; 17: 719–34 DOI:10.1097/00004872–199917060–00001Grassi G., Turri C., Vailati S., Dell’Oro R., Mancia G. Muscle and skin sympathetic nerve traffic during the white-coat effect. Circulation. 1999; 100: 222–5 DOI:10.1161/01.cir.100.3.222Grassi G., Turri C., Vailati S., Dell’Oro R., Mancia G. Muscle and skin sympathetic nerve traffic during the white-coat effect. Circulation. 1999; 100: 222–5 DOI:10.1161/01.cir.100.3.222Ogedegbe G., Pickering T.G., Clemow L., Chaplin W., Spruill T.M., Albanese G.M. The misdiagnosis of hypertension: the role of patient anxiety. Arch. Intern. Med. 2008; 168: 2459–65 DOI:10.1001/archinte.168.22.2459Ogedegbe G., Pickering T.G., Clemow L., Chaplin W., Spruill T.M., Albanese G.M. The misdiagnosis of hypertension: the role of patient anxiety. Arch. Intern. Med. 2008; 168: 2459–65 DOI:10.1001/archinte.168.22.2459Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension. 2009; 54: 690–7 DOI:10.1161/hypertensionaha.108.119883Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension. 2009; 54: 690–7 DOI:10.1161/hypertensionaha.108.119883Smith P.A., Graham L.N., Mackintosh A.F., Stoker J.B., Mary D.A. Relationship between central sympathetic activity and stages of human hypertension. Am. J. Hypertens. 2004; 17: 217–22 DOI:10.1016/j.amjhyper.2003.10.010Smith P.A., Graham L.N., Mackintosh A.F., Stoker J.B., Mary D.A. Relationship between central sympathetic activity and stages of human hypertension. Am. J. Hypertens. 2004; 17: 217–22 DOI:10.1016/j.amjhyper.2003.10.010Curgunlu A., Uzun H., Bavunoğlu I., Karter Y., Genç H., Vehid S. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension. J. Hum. Hypertens. 2005; 19: 629–33 DOI:10.1038/sj.jhh.1001867Curgunlu A., Uzun H., Bavunoğlu I., Karter Y., Genç H., Vehid S. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension. J. Hum. Hypertens. 2005; 19: 629–33 DOI:10.1038/sj.jhh.1001867Franklin S.S., Th ijs L., Hansen T.W., Li Y., Boggia J., Kikuya M. et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension. 2012; 59: 564–71 DOI:10.1161/hypertensionaha.111.180653Franklin S.S., Th ijs L., Hansen T.W., Li Y., Boggia J., Kikuya M. et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension. 2012; 59: 564–71 DOI:10.1161/hypertensionaha.111.180653Verdecchia P., Reboldi G.P., Angeli F., Schillaci G., Schwartz J.E., Pickering T.G. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005; 45: 203–8 DOI:10.1161/01.hyp.0000151623.49780.89Verdecchia P., Reboldi G.P., Angeli F., Schillaci G., Schwartz J.E., Pickering T.G. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension. 2005; 45: 203–8 DOI:10.1161/01.hyp.0000151623.49780.89Pierdomenico S.D., Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am. J. Hypertens. 2011; 24: 52–8 DOI:10.1038/ajh.2010.203Pierdomenico S.D., Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am. J. Hypertens. 2011; 24: 52–8 DOI:10.1038/ajh.2010.203Hänninen M.R., Niiranen T.J., Puukka P.J., Johansson J., Jula A.M. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study. J. Hypertens. 2012; 30(4): 705–12 DOI:10.1097/hjh.0b013e328350a69bHänninen M.R., Niiranen T.J., Puukka P.J., Johansson J., Jula A.M. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study. J. Hypertens. 2012; 30(4): 705–12 DOI:10.1097/hjh.0b013e328350a69bSipahioglu N.T., Sipahioglu F. Closer look at white-coat hypertension. World J. Methodol. 2014; 26: 144–50 DOI:10.5662/wjm.v4.i3.144Sipahioglu N.T., Sipahioglu F. Closer look at white-coat hypertension. World J. Methodol. 2014; 26: 144–50 DOI:10.5662/wjm.v4.i3.144Mancia G., Bombelli M., Facchetti R., Madotto F., Quarti-Trevano F., Friz H.P. et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009; 54: 226–32 DOI:10.1161/hypertensionaha.109.129882Mancia G., Bombelli M., Facchetti R., Madotto F., Quarti-Trevano F., Friz H.P. et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009; 54: 226–32 DOI:10.1161/hypertensionaha.109.129882Gustavsen P.H., Hoegholm A., Bang L.E., Kristensen K.S. White coat hypertension is a cardiovascular risk factor: A 10-year follow-up study. J. Hum. Hypertens. 2003;17: 811–7 DOI:10.1038/sj.jhh.1001643Gustavsen P.H., Hoegholm A., Bang L.E., Kristensen K.S. White coat hypertension is a cardiovascular risk factor: A 10-year follow-up study. J. Hum. Hypertens. 2003;17: 811–7 DOI:10.1038/sj.jhh.1001643Stergiou G.S., Asayama K., Thijs L., Kollias A., Niiranen T.J., Hozawa A. et al. Prognosis of white-coat and masked hypertension: International Database of Home blood pressure in relation to Cardiovascular Outcome. Hypertension. 2014; 63(4): 675–82 DOI:10.1161/HYPERTENSIONAHA.113.02741Stergiou G.S., Asayama K., Thijs L., Kollias A., Niiranen T.J., Hozawa A. et al. Prognosis of white-coat and masked hypertension: International Database of Home blood pressure in relation to Cardiovascular Outcome. Hypertension. 2014; 63(4): 675–82 DOI:10.1161/HYPERTENSIONAHA.113.02741Briasoulis A., Androulakis E., Palla M., Papageorgiou N., Tousoulis D. White-coathypertension and cardiovascular events: a meta-analysis. J. Hypertens. 2016; 34(4): 593–9 DOI:10.1097/hjh.0000000000000832Briasoulis A., Androulakis E., Palla M., Papageorgiou N., Tousoulis D. White-coathypertension and cardiovascular events: a meta-analysis. J. Hypertens. 2016; 34(4): 593–9 DOI:10.1097/hjh.0000000000000832Huang Y., Huang W., Mai W., Cai X., An D., Liu Z. et al. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J of Hypertension. 2017; 35: 677–88 DOI:10.1097/hjh.0000000000001226Huang Y., Huang W., Mai W., Cai X., An D., Liu Z. et al. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J of Hypertension. 2017; 35: 677–88 DOI:10.1097/hjh.0000000000001226Cuspidi C., Rescaldani M., Tadic M., Sala C., Grassi G., Mancia G. White-coat hypertension, as defi ned by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis. J. Hypertens. 2015; 33(1): 24–32 DOI:10.1097/hjh.000000000000041Cuspidi C., Rescaldani M., Tadic M., Sala C., Grassi G., Mancia G. White-coat hypertension, as defi ned by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis. J. Hypertens. 2015; 33(1): 24–32 DOI:10.1097/hjh.000000000000041Muscholl M.W., Hense H.W., Bröckel U., Döring A., Riegger G.A., Schunkert H. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ. 1998; 317: 565–70 DOI:10.1136/bmj.317.7158.565Muscholl M.W., Hense H.W., Bröckel U., Döring A., Riegger G.A., Schunkert H. Changes in left ventricular structure and function in patients with white coat hypertension: cross sectional survey. BMJ. 1998; 317: 565–70 DOI:10.1136/bmj.317.7158.565Owens P.E., Lyons S.P., Rodriguez S.A., O’Brien E.T. Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ changes? J. Hum. Hypertens. 1998; 12: 743–8 DOI:10.1038/sj.jhh.1000721Owens P.E., Lyons S.P., Rodriguez S.A., O’Brien E.T. Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ changes? J. Hum. Hypertens. 1998; 12: 743–8 DOI:10.1038/sj.jhh.1000721Cuspidi C., Sala C., Tadic M., Rescaldani M., Grassi G., Mancia G. Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis. Blood. Press. Monit. 2015; 20(2): 57–63 DOI:10.1097/MBP.0000000000000094Cuspidi C., Sala C., Tadic M., Rescaldani M., Grassi G., Mancia G. Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis. Blood. Press. Monit. 2015; 20(2): 57–63 DOI:10.1097/MBP.0000000000000094Hara A., Ohkubo T., Kikuya M., Shintani Y., Obara T., Metoki H. et al. Detection of carotid atherosclerosis in individuals with masked hypertension and white-coat hypertension by self-measured blood pressure at home: the Ohasama study. J. Hypertens. 2007; 25: 321–7 DOI:10.1097/hjh.0b013e3280115bbfHara A., Ohkubo T., Kikuya M., Shintani Y., Obara T., Metoki H. et al. Detection of carotid atherosclerosis in individuals with masked hypertension and white-coat hypertension by self-measured blood pressure at home: the Ohasama study. J. Hypertens. 2007; 25: 321–7 DOI:10.1097/hjh.0b013e3280115bbfPuato M., Palatini P., Zanardo M., Dorigatti F., Tirrito C., Rattazzi M. et al. Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Hypertension. 2008; 51: 1300–5 DOI:10.1161/hypertensionaha.107.106773Puato M., Palatini P., Zanardo M., Dorigatti F., Tirrito C., Rattazzi M. et al. Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Hypertension. 2008; 51: 1300–5 DOI:10.1161/hypertensionaha.107.106773Wimmer N.J., Sathi K., Chen T.L., Townsend R.R., Cohen D.L. Comparison of pulse wave analysis between persons with white coat hypertension and normotensive persons. J. Clin. Hypertens. 2007; 9: 513–7 DOI:10.1111/j.1524–6175.2007.06553.xWimmer N.J., Sathi K., Chen T.L., Townsend R.R., Cohen D.L. Comparison of pulse wave analysis between persons with white coat hypertension and normotensive persons. J. Clin. Hypertens. 2007; 9: 513–7 DOI:10.1111/j.1524–6175.2007.06553.xKarter Y., Aydin S., Curgunlu A., Uzun H., Ertürk N., Vehid S. et al. Endothelium and angiogenesis in white coat hypertension. J. Hum. Hypertens. 2004; 18: 809–14 DOI:10.1038/sj.jhh.1001752Karter Y., Aydin S., Curgunlu A., Uzun H., Ertürk N., Vehid S. et al. Endothelium and angiogenesis in white coat hypertension. J. Hum. Hypertens. 2004; 18: 809–14 DOI:10.1038/sj.jhh.1001752Guven A., Tolun F., Caliskan M. C-reactive protein and nitric oxide level in patients with white coat hypertension. Blood Press. 2012; 21: 281–5 DOI:10.3109/08037051.2011.649541Guven A., Tolun F., Caliskan M. C-reactive protein and nitric oxide level in patients with white coat hypertension. Blood Press. 2012; 21: 281–5 DOI:10.3109/08037051.2011.649541Cloutier L., Daskalopoulou S.S., Padwal R.S., Lamarre-Cliche M., Bolli P., McLean D. et al. A New Algorithmfor the Diagnosisof Hypertensionin Canada. Can. J. Cardiol. 2015; 31(5): 620–30 DOI:10.1016/j.cjca.2015.02.014Cloutier L., Daskalopoulou S.S., Padwal R.S., Lamarre-Cliche M., Bolli P., McLean D. et al. A New Algorithmfor the Diagnosisof Hypertensionin Canada. Can. J. Cardiol. 2015; 31(5): 620–30 DOI:10.1016/j.cjca.2015.02.014Myers M.G., Valdivieso M., Kiss A. Use of automated pressure measurement to reduce the white coat response. J. Hypertens. 2009; 27: 280–6 DOI:10.1097/hjh.0b013e32831b9e6bMyers M.G., Valdivieso M., Kiss A. Use of automated pressure measurement to reduce the white coat response. J. Hypertens. 2009; 27: 280–6 DOI:10.1097/hjh.0b013e32831b9e6bЦфасман А.З. Профессия и гипертония. М., 2012: 192.Сfasman А.Z. Profession and hypertension. М.; 2012 (in Russian).

The authors declare that there are no conflicts of interest present.